Share this:
Aprecia Pharmaceuticals, the company behind the first FDA approved 3D printed drug Spritam, has entered into a long-term collaboration with private non-profit research and development (R&D) firm, Battelle. The partnership will expand Aprecia’s capabilities within 3D printed pharmaceuticals through increasing manufacturing throughput and efficiency, in addition to advancing its 3D printing equipment from clinical supply […]
This article was first featured at https://3dprintingindustry.com/news/aprecia-partners-with-battelle-to-scale-up-3d-printed-pharmaceutical-manufacturing-181629/?utm_source=rss&utm_medium=rss&utm_campaign=aprecia-partners-with-battelle-to-scale-up-3d-printed-pharmaceutical-manufacturing on January 4, 2021 at 06:48AM by Hayley Everett
More Stories
Can this possibly be true? “Metal 3D printing is now possible on any 3D printer…with the right settings and a few minor upgrades like a hardened steel nozzle…” – July 2 2023 at 04:59PM
New NASA Funding Ignites 25 3D Printing Projects in Space Exploration – June 18 2023 at 04:34PM
Nvidia AI produces 3D models from 2D videos 3D printing applications forthcoming? – June 15 2023 at 02:55AM